Sujay Shetty’s Post

In the dynamic landscape of provider practices, increasing consolidation is reshaping the industry. Healthcare systems, payers, and private equity are swiftly acquiring formerly independent practices, altering ownership structures and influencing provider priorities and accessibility. This consolidation also impacts prescribing patterns, pressuring manufacturers for discounts via providers. Standardized care protocols are emerging under unified ownership and altering treatment decisions driven by financial incentives. Vertical integration further enhances this trend, fostering better medical benefit oversight. Providers, key to accessibility, face challenges in adapting to evolving standards and financial constraints. To regain control, they're implementing operational models, necessitating pharmaceutical companies to strategize localized pricing to minimize redundancies and maximize efficiency. #Healthcare #Pharma #PayerProviderRelationship #Pharmaceuticals

Ensure Patient Safety with the innovative BPAMedical365®, https://lnkd.in/dUkTS5PZ ⭐ Top pharma trends and predictions for 2024, https://lnkd.in/dGKF6G6v #fda #iso13485 #mdr #healthcare #patientsafety #regulatoryaffairs #trends #pharma #hospitals #qualitymanagement

Key trends going forward: a changing healthcare landscape Growth prospects in developed markets will continue to be influenced by a changing #healthcare landscape, noted Lewis. Payers will prioritize their focus on healthcare delivery efficiencies, but rationalize #pharma #spending to achieve better cost control. Outlines the key issues at play, ultimately resulting in more payer influence in pharma spending levels. Payer management of #pharmaceuticals is expected to increase with stricter market access and pricing pressure, and some healthcare costs and responsibility for healthcare will be redirected to consumers.

How helpful do you find your interactions with pharma? At EMJ, we believe that building trust between healthcare professionals and the pharma industry is key to delivering the best outcomes for patients, so discover the current state of play in the latest EMJ GOLD infographic.

Patient centricity is increasingly recognized as essential in aligning healthcare with the real needs and preferences of those it serves. This approach underlines the importance of integrating patient perspectives into all phases of healthcare, from research to policy implementation. Despite advances in incorporating patient input into drug development and health assessments, ongoing challenges exist. Effective and early engagement of patients in the research process remains a key goal. The focus is on creating a healthcare environment where patient experiences and outcomes directly influence research and policy. Our aim is to build a system that genuinely listens to and acts upon the voices of patients, ensuring that patient-centricity is a practical reality in all aspects of healthcare. #HEOR #reimbursement #costeffectiveness #pharmaceuticals #HTA #marketacces #HealthEconomics #ISPOR #patientcentricity

Trust is the foundation of any relationship, but not all healthcare professionals would give pharma a perfect 10. At EMJ GOLD, we believe that building trust between HCPs and pharma is key to delivering the best outcomes for patients, so discover the current state of play in our latest infographic. Find out how pharma's reputation stacks up against other industries and take note of key recommendations that could elevate its scores to the next level. View the infographic here: https://hubs.la/Q02wGJdL0 #Trust #Pharma #Healthcare #Science

Equal access to medicines is one of the most pressing issues our generation must overcome. In response, we built our Axmed Platform - a pioneering marketplace designed to make high-quality, affordable medicines available in low- and middle-income countries. It leverages innovative technology to bridge the gap between manufacturers and the healthcare needs of developing regions. Partnering with Axmed allows organizations to tap into a comprehensive network of healthcare solutions designed to improve patient outcomes. We offer innovative data & analytics capabilities, strategic consultancy, and a commitment to making high-quality healthcare accessible to all. Our business model automizes demand consolidation at an unprecedented scale on the buying end. It leverages volume benefits for patients and healthcare providers, all the while expediting access to groundbreaking innovations by facilitating sustainable commercial approaches for pharmaceutical companies in markets where patient acquisition costs have prevented efficient access until today. Learn more about Axmed at axmed.com and remember, you can join the waitlist as we get ready for our Open Release on January 30th: https://lnkd.in/dshp2C7x 🚀 #MedicineAccess #B2BMarketplace #PharmaPartnerships #HealthTech #medicines

One issue continues to loom large in healthcare: the skyrocketing costs of pharmaceuticals. This challenge has become a significant hurdle for managed healthcare organizations, patients, and policymakers alike. As we delve into this complex topic, we’ll explore the various factors contributing to rising drug prices, their impact on the healthcare system, and potential solutions to address this pressing concern. https://lnkd.in/eeEMcnbN

One issue continues to loom large in healthcare: the skyrocketing costs of pharmaceuticals. This challenge has become a significant hurdle for managed healthcare organizations, patients, and policymakers alike. As we delve into this complex topic, we'll explore the various factors contributing to rising drug prices, their impact on the healthcare system, and potential solutions to address this pressing concern. https://lnkd.in/eeEMcnbN

Sharing this insightful article on the growing MENA pharma market!🚀 Projected to reach USD 60 billion by 2025, this article highlights crucial trends like data-driven reimbursement, innovative contracting, and health technology assessments that are shaping the future of pharma market access in MENA. 📈 Check out the full article below: 📍https://lnkd.in/dTjKqiSS #SyenzaInsights #MarketAccess #MENA #HealthcareInnovation #Pharmaceuticals